How Does the COVID-19 Antiviral Medications Workflow Compare to the Traditional Antiviral Production Pipeline

 

As the COVID-19 pandemic continues to progress researchers and scientists are starting to learn more about the virus in order to effectively combat it. One of those lessons is how the COVID-19 virus compares to other viruses when it comes to developing treatments. Justin Honore talked to Dr. Kishor Wasan, PH.D.,FAAPS, FCAHS, FCSPS, Chief Medical & Scientific Officer at Skymount Medical and a Distinguished University Scholar Adjunct Professor at the University of British Columbia about how COVID-19 vaccine research and production compare to the traditional antiviral and antibiotic production pipeline.

Follow us on social media for the latest updates in B2B!

Latest

irish whiskey barrels
E.U. Whiskey Tariffs Are Lifted, But the Industry is Still On the Rocks
January 21, 2022
  The whiskey market is eager for a return to form. In 2018, in response to the U.S. steel and aluminum tariffs targeting the E.U. and ordered by former President Donald Trump, the European Read more
Material Signs: Introduction to the World of Optics
January 21, 2022
Doctors Scott Carney, chief science and technology officer at Optica, Kate Medicus, CEO at Ruda-Cardinal, and Alexis Vogt, endowed chair and professor of optics at Monroe Community College, joined Host Tyler Read more
What Defines "Success" for Safety Personnel?
What Defines “Success” for Safety Personnel?
January 21, 2022
The Safety Justice League is back and refreshed after a much-needed, restful holiday season. Jason squared (Jason Maldonado and Jason Lucas) joined Host Abby Ferri to dive into what success looks like Read more